IMS Health Holdings Inc. (NYSE:IMS) rose 2.8% during mid-day trading on Thursday . The company traded as high as $28.31 and last traded at $28.30, with a volume of 1,455,565 shares. The stock had previously closed at $27.53.

IMS has been the topic of a number of analyst reports. Zacks Investment Research downgraded IMS Health Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday. Topeka Capital Markets increased their price target on IMS Health Holdings from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Wednesday, May 4th. Piper Jaffray Cos. reissued an “overweight” rating and set a $32.00 price target (up previously from $28.00) on shares of IMS Health Holdings in a research report on Thursday, March 24th. Finally, Wells Fargo & Co. downgraded IMS Health Holdings from an “outperform” rating to a “market perform” rating in a research report on Thursday, May 12th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and six have given a buy rating to the stock. IMS Health Holdings presently has an average rating of “Buy” and an average price target of $31.22.

The stock has a market capitalization of $9.19 billion and a P/E ratio of 57.21. The company’s 50-day moving average price is $25.85 and its 200 day moving average price is $25.39.

IMS Health Holdings (NYSE:IMS) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $0.42 EPS for the quarter, topping analysts’ consensus estimates of $0.38 by $0.04. During the same period last year, the firm posted $0.39 EPS. The company earned $774 million during the quarter, compared to the consensus estimate of $749.34 million. The company’s revenue for the quarter was up 22.5% compared to the same quarter last year. On average, equities analysts predict that IMS Health Holdings Inc. will post $1.60 earnings per share for the current fiscal year.

Several large investors recently bought and sold shares of IMS. Deimos Asset Management LLC bought a new stake in IMS Health Holdings during the fourth quarter worth approximately $1,296,000. Gulf International Bank UK Ltd bought a new stake in IMS Health Holdings during the fourth quarter worth approximately $1,338,000. Cornerstone Capital Management Holdings LLC. bought a new stake in IMS Health Holdings during the fourth quarter worth approximately $1,430,000. Oxford Asset Management bought a new stake in IMS Health Holdings during the fourth quarter worth approximately $1,574,000. Finally, Great West Life Assurance Co. Can boosted its stake in IMS Health Holdings by 85.4% in the fourth quarter. Great West Life Assurance Co. Can now owns 76,933 shares of the company’s stock worth $1,959,000 after buying an additional 35,431 shares during the period.

IMS Health Holdings, Inc (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company’s data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.